Hologic Inc. logo

Hologic Inc. (HOLX)

Market Closed
17 Dec, 21:00
NASDAQ (NGS) NASDAQ (NGS)
$
74. 93
-0.09
-0.12%
After Hours
$
79. 02
+4.09 +5.46%
16.67B Market Cap
38.79 P/E Ratio
0% Div Yield
4,309,691 Volume
3.91 Eps
$ 75.02
Previous Close
Day Range
74.91 75.19
Year Range
51.9 75.34
Want to track HOLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 48 days
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Zacks | 3 months ago
HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?

HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?

Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.

Zacks | 3 months ago
Here's Why Hologic (HOLX) is a Strong Value Stock

Here's Why Hologic (HOLX) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 months ago
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?

What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?

HOLX's Genius digital cytology system and global rollout position its Cytology unit for long-term growth despite near-term headwinds.

Zacks | 3 months ago
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?

Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 4 months ago
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength

Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength

HOLX targets a mid-single-digit organic growth rebound in 2026, powered by Breast Health recovery and new product innovation.

Zacks | 4 months ago
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?

Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?

HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.

Zacks | 4 months ago
Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings?

Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings?

HOLX rises post earnings beat, fueled by Diagnostics strength and Surgical growth. However, macro headwinds persist.

Zacks | 4 months ago
Why Hologic (HOLX) is a Top Value Stock for the Long-Term

Why Hologic (HOLX) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 4 months ago
Interpreting Hologic (HOLX) International Revenue Trends

Interpreting Hologic (HOLX) International Revenue Trends

Evaluate Hologic's (HOLX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Zacks | 4 months ago
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 4 months ago
Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down

Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down

HOLX posts better-than-expected Q3 results, but margin contraction and regional headwinds pressure investor sentiment.

Zacks | 4 months ago
Loading...
Load More